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Abstract 
Pre-eclampsia (PE) is characterized by an exaggerated systemic inflammatory response and 
generalized endothelial dysfunction. We have recently demonstrated that fibrinogen, an 
endogenous ligand of Toll-like receptor (TLR) 4, activates monocytes from women with pre-
eclampsia (Al-ofi et al., 2014). Using an experimental co-culture model of primary human 
monocytes (derived from 9 women with PE (GA=33.18 ± 5.8) and 9 normotensive pregnant 
women, NP (GA= 33.15 ± 4.0)) and human umbilical venous endothelial cells (HUVECs), we 
compared the effects of fibrinogen  and lipopolysaccharide (LPS, bacterial ligand to TLR4) on 
the expression levels of inflammatory cytokines (IL-6 and IL-1β), chemokines (IL-8 and MCP-
1),  and anti-angiogenic factor (soluble fms-like tyrosine kinase-1,sFLT-1), as well as the 
soluble vascular cell adhesion molecule-1 (sVCAM-1). Cytokines, VEGF and sVCAM-1 were 
measured in the supernatant media by cytometric array. The levels of sFLT-1 were 
measured by ELISA.  Fibrinogen induced greater expression levels of IL-1β and VCAM-1 
from PE HUVEC-monocyte co-culture than from NP HUVEC-monocyte co-culture (P<0.05), 
similar to the effects of LPS. In contrast, unlike LPS, fibrinogen suppressed IL-6, IL-8, MCP-1 
and sFLT-1 production by co-cultures that included PE monocytes compared to those with 
NP monocytes (P<0.05). In conclusion, fibrinogen promotes monocyte-endothelial cell 
adhesion and angiogenesis and suppresses the expression of some inflammatory markers in 
pre-eclampsia.  Although the physiological implications of these intriguing observations are 
unclear our findings suggest that fibrinogen contributes to the regulation of cell adhesion, 
angiogenesis and inflammation by mechanisms not wholly dependent on TLR4 stimulation. 
 
Keywords: Pregnancy hypertensive disorder; Endothelial cells; Monocytes; TLR4; 
Endogenous ligand 
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1.1 Introduction 
 Pre-eclampsia (PE) is defined as pregnancy-induced hypertension associated with 
proteinuria that occurs after mid of pregnancy (Brown et al., 2001). The etiology of PE 
remains unclear but a number of pathophysiologic mechanisms of the disorder have now 
been clarified. PE is characterized by increased circulating levels of the anti-angiogenic 
factor soluble fms-like tyrosine kinase-1 (sFLT-1) but suppressed levels of the pro-angiogenic 
factors free vascular endothelial growth factor (VEGF) and placental growth factor (PIGF) 
(Widmer et al., 2015). Increased levels of circulating markers of endothelial cell damage such 
as vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 
(ICAM-1) have also been described (Veas et al., 2011, Prochazka et al., 2015). Altered 
activation and function of circulating inflammatory cells such as monocytes (Sibai, 2004, Al-
ofi et al., 2012) as well as a changes in their subpopulations, and exaggerated responses to 
toll-like receptor (TLR) 2 and 4 ligands have been described (Al-ofi et al., 2012). All of these 
observations suggest that vascular endothelial cell dysfunction and altered immunological 
responses play major roles in the pathogenesis of PE. 
 
It has been recognized that the interaction between peripheral blood monocytes and vascular 
endothelial cells alters the expression of various inflammatory mediators: the co-culture of 
monocytes with endothelial cells has been shown to induce more inflammatory markers 
(such as IL-6, IL-1β, IL-1α, IL-8, MCP-1, IFN γ-inducible protein 10, and granulocyte-
macrophage colony-stimulating factor, GM-CSF) and adhesion molecules than the 
monoculture of either cell type individually (Lukacs et al., 1995, Takahashi et al., 1996, 
Kasama et al., 2002, Ward et al., 2009). Monocytes appear to play key roles in the regulation 
of endothelial cell proliferation and survival, as well as angiogenesis, (Schubert et al., 2011). 
Furthermore, they are activated in PE, as shown by us (Al-ofi et al., 2012) and others 
(Gervasi et al., 2001, Luppi and Deloia, 2006). For example, CD11 and reactive oxygen 
species are upregulated in PE monocytes (Gervasi et al., 2001). 
 
Fibrinogen, an endogenous ligand of TLR4 is also able to bind and activate the signaling of 
immune cells (i.e. monocytes) via CD11b/CD18 integrin receptors and adhesion molecules 
(Hodgkinson et al., 2008). During normal pregnancy, plasma fibrinogen is increased and 
fibrinolysis activity is suppressed, ostensibly to promote coagulability of blood (Thornton and 
Douglas, 2010). There are conflicting data regarding fibrinogen levels in PE, with some 
studies, including ours, demonstrating increased (Al-ofi et al., 2014, Kawada, 2015), whilst 
others demonstrate reduced, circulating levels (Spiezia et al., 2015). Moreover, 
immunofluorescence microscopy has revealed fibrin deposition in the vascular compartments 
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of the placenta, kidney and liver in severe PE (Arias and Mancilla-Jimenez, 1976, Roberts 
and Post, 2008, Al-ofi et al., 2014) 
 
We recently showed that fibrinogen activates monocytes from women with PE (Al-ofi et al., 
2014). We therefore postulated that fibrinogen-induced activation of “inflammatory” 
monocytes in PE could impair vascular endothelial cell function and alter their chemo-
attractant, angiogenic and inflammatory responses, thus playing a key role in the 
pathogenesis of PE. We tested this hypothesis by comparing the responses to fibrinogen and 
LPS of HUVECs co-incubated with PE monocytes to the responses of HUVECs co-incubated 
with monocytes from normotensive women matched for gestation. We chose fibrinogen and 
HMGB1 as the endogenous ligands of TLR4 having demonstrated in an earlier study that, of 
the TLR4 ligands studied, fibrinogen was the only factor that appeared to induce 
inflammatory cytokine release from PE monocyte cultures (Al-ofi et al., 2014). Our co-culture 
experimental model enabled us to determine the effects of these TLR4 ligands on the 
expression levels of inflammatory cytokines (IL-6 and IL-1β), chemokines (IL-8 and MCP-1), 
angiogenic (VEGF) and anti-angiogenic (sFLT-1) factors, as well as the cell adhesion 
molecule sVCAM-1.  
 
 1.2 Material and Method 
1.2.1 Ethical approval  
Ethical approval for this study was received from the South Yorkshire Research Ethics 
Committee (09/H1310/12). A detailed information sheet was given to all study participants 
and written informed consent was obtained from them. 
 
1.2.2 Subjects and samples 
Consent for use of umbilical cords was obtained from term normotensive pregnant women in 
early labour in the delivery suite of the Jessop Wing Hospital (n=12). The harvested umbilical 
cords were used for the isolation of HUVECs. Monocytes were obtained from blood samples 
from nine women with PE and nine NP women (Table1), and used for HUVEC co-culture 
experiments. 10ml of fresh blood was collected into a tube containing EDTA to prevent 
clotting and immediately transported to the research laboratories to isolate monocytes for the 
experiments.  
 
1.2.3 Stimulation of monocytes and HUVEC cultures 
Co-culture experiments of primary human monocytes and endothelial cells were optimized 
according to previously published studies (Schubert et al., 2008, Ward et al., 2009). Human 
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vascular endothelial cells were isolated from freshly collected umbilical cords using standard 
published techniques (Baudin et al., 2007). The HUVECs were then cultured and studied on 
the second through fifth passages.  HUVECs were seeded onto 0.2% gelatin-coated 12-well 
tissue-culture plates (Greiner bio-one, catalogue number: 665180) at a density of 105 cells 
per well and incubated with one ml of medium (DMEM supplemented with 10% heat-
inactivated FBS, 2 mM L-Glutamine and penicillin-streptomycin) at 37°C with 5% CO2 until 
they reached 70-90% of confluence, usually within two to three days. The day before the 
experiment, the cells were washed with 1ml of pre-warmed PBS and cultured with low serum 
media (DMEM supplemented with 5% heat inactivated FBS without antibiotics) for serum 
starvation. 
 
 The monocytes were isolated from the fresh blood of donors (NP or PE), collected in EDTA 
tubes and separated immediately after the blood was drawn. Peripheral blood mononuclear 
cells (PBMCs) were isolated by density gradient centrifugation on top of Ficoll-Paque (Al-ofi 
et al., 2012). Monocytes were isolated from PBMCs using the pan monocyte isolation kit 
(Miltenyi Biotic, Bergisch Gladbach, Germany catalogue number: 130-096-537), which 
employs indirect magnetic labelling of non-monocyte cells, according to the manufacturer’s 
instructions. 
 
Following 24h of serum starvation, HUVECs were washed with 1ml of pre-warmed PBS and 
low serum media was replaced (DMEM supplemented with 5% heat inactivated FBS without 
antibiotics). Monocytes were plated at a density of 20,000 cells/ml on top of HUVECs at the 
approximate proportion of 1 monocyte to 5 HUVECs. At the same time, monocytes or 
HUVECs were cultured separately with the equivalent density (mono-cultures). Mono-culture 
and co-culture assays were performed in DMEM with 5% heat-inactivated FBS without 
antibiotics media.  Thereafter, mono- and co-cultures were immediately stimulated with 100 
ng/ml lipopolysaccharides (rough strains) from Escherichia coli EH 100 (Sigma-Aldrich), 5 
μg/ml peptidoglycan from Staphylococcus aureus (Sigma-Aldrich), 2 mg/ml fibrinogen from 
human plasma (Sigma-Aldrich), and 0.7 μg/ml recombinant human HMGB1 (R and D 
Systems), as described in previous studies (Smiley et al., 2001, Yu et al., 2006), by 24h of 
incubation at 37°C with 5% CO2. After 24h, the conditioned medium was collected and stored 
at -80°C. 
 
 1.2.4 Flow cytometry 
Flow cytometry was used to confirm the presence of monocyte and endothelial cell 
populations in the co-culture experimental models as depicted in the Fig 1.  
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1.2.5 Cytometric bead array 
The cytometric bead array (CBA) technique was used to measure the inflammatory cytokines 
(IL-1 and IL-6), the anti-inflammatory cytokine (IL-10), and chemokines (IL-8 and MCP-1) 
within conditioned medium collected from monocytes and the HUVECs cultures. This assay 
was performed as previously described using kits from BD Biosciences, a BD FACS Array 
flow cytometry machine and FCAP Array software. The IL-1 and IL-10 cytokines were 
measured in the undiluted aliquot (30μl). However, IL-6, IL-8 and MCP-1 cytokines were 
above standard levels for undiluted aliquots. Consequently, serial dilutions (1:10 up to 1:200) 
were attempted to optimize the desired dilution. Thereafter, according to the optimum 
concentration within the sample, either 1:50 or 1:100 dilutions were applied to the samples, 
and each sample was multiplied according to its dilution factor before analysis was initiated. 
Additionally, The CBA technique was used to measure the VEGF and sVCAM-1 in the 
supernatant medium collected from monocytes-HUVECs mono- or co-cultures. 
 
1.2.6 Enzyme-linked Immunosorbent Assay  
Human sVEGFR-1 / sFLT-1 Immunoassay (Quantikine ELISA kit catalogue number: 
DVR100B, R&D Systems, Europe) was used for the quantitative determination of human 
sFLT-1 concentrations in cell culture supernatants. All measurements were made in triplicate 
on 1:5 dilutions of the culture media.  
 
1.2.7 Statistical analysis 
The results are illustrated as mean ± standard error of the mean (SEM). One-way ANOVA 
(Kruskal-Wallis test), followed by correction using Dunn's multiple comparisons test, was 
used to compare differences between mono-cultures of HUVECs and monocytes, as well as 
between co-cultures of NP/PE monocytes and HUVECs, using GraphPad Prism software 
version 7.0. The two-way ANOVA test was used to compare differences between the 
unstimulated cells and the cells stimulated with different agonists (bacterial and endogenous 
ligands of TLRs). P values < 0.05 were considered significantly different.  
 
1.3 Results 
1.3.1 Monocytes of women with PE alter inflammatory responses of vascular 
endothelial cells in co-culture experimental model (Figure 2) 
In comparison with NP co-cultures, unstimulated co-cultures of PE monocytes with 
endothelial cells demonstrated profoundly increased secretion of the inflammatory cytokine 
IL-6 (P<0.05) as well as the chemokines IL-8 and MCP-1(Fig 2A, 2D and 2E respectively) 
(P<0.01), along with reduced production of the anti-inflammatory cytokine IL-10 (Fig 2C). 
 
 7 
Additionally, unstimulated monocyte-HUVEC co-cultures from NP and PE groups released 
significantly higher IL-6 levels than monocyte monocultures; IL-6 expression from HUVEC-
PE monocyte co-cultures was more than 10-fold higher than from PE monocyte 
monocultures (P<0.05) (Fig 2A). Furthermore, HUVEC-PE monocyte co-cultures produced 
much higher basal levels of IL-8 than PE monocyte monocultures (P<0.05) (Fig 2D).  Basal 
expression levels of IL-1β and IL-10 did not differ between PE mono- and co-cultures (Fig 2B 
and 2C respectively).  HUVECs and NP/PE monocytes in monocultures did not produce 
MCP-1.  Conversely, when both cell types interacted during co-cultures experiments, there 
was a significant increase in MCP-1 production, especially from HUVEC-PE monocyte co-
cultures (P<0.001) (Fig 2E). 
 
1.3.2 Fibrinogen alters inflammatory responses of monocytes from women with PE co-
cultured with vascular endothelial cells (Figure 3)  
After stimulation with LPS, IL-6 significantly increased in both NP and PE co-culture models 
(P<0.05 and P<0.001) (Fig 3A). Compared with NP, TLR bacterial ligand-treated HUVEC-PE 
monocyte co-cultures exhibited markedly increased IL-6 secretion, compared to that seen in 
ligand-treated HUVEC-NP monocytes (P<0.01). In contrast, endogenous ligands of TLR4 
evoked no such increase in NP as well as PE monocyte co-cultures.  
 
LPS, PDG, and fibrinogen significantly induced IL-1β secretion by PE monocytes, with or 
without HUVECs, when compared to the non-stimulated control (P<0.05 and P<0.001) (Fig 
3B). Additionally, LPS and PDG significantly induced IL-1β in HUVEC-NP monocytes when 
compared to non-stimulated control (P<0.05). Fibrinogen-treated HUVEC-PE monocytes 
exhibited a marked increase in IL-1β secretion compared to fibrinogen-treated HUVEC-NP 
monocytes (P<0.05). However, unlike IL-6 and IL- β, IL-10 expression levels did not differ 
between ligand-treated HUVEC-monocyte co-cultures from PE and NP groups (Fig 3C). 
 
Compared to non-stimulated-HUVEC-PE monocyte co-cultures, LPS and PDG induced IL-8 
secretion whilst fibrinogen appeared to suppress it and HMGB1 did not alter its basal 
secretion (Fig 3D). In contrast, all ligands significantly induced IL-8 in HUVEC-NP monocyte 
co-cultures compared to un-stimulated co-cultures (P<0.05).  
 
Compared to non-stimulated controls, MCP-1 was released in large amounts from PDG-
treated HUVEC-PE monocyte co-cultures (P<0.001); was not produced by LPS-treated 
HUVEC-PE monocyte co-cultures; and was suppressed in fibrinogen-HUVEC-PE monocyte 
co-cultures (Fig 3E).  
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1.3.3 Fibrinogen attenuates sFLT-1-induced dys-angiogenesis (Figure 4) 
Human vascular endothelial cell monocultures produced high basal levels of sFLT-1. 
However, this appeared down-regulated by co-culture with monocytes from both groups of 
pregnant women (P<0.001), NP monocytes more so than PE monocytes (P<0.05) (Fig 4A1). 
Although the treatment of HUVEC monocultures with LPS or PDG appeared to reduce sFLT-
1 production, this observation did not attain statistical significance (Fig 4A2). On the other 
hand, stimulation of co-cultures with bacterial ligands induced sFLT-1 production in both NP 
and women with PE (Fig 4A2). Fibrinogen treatment of HUVEC-PE monocyte co-cultures 
significantly reduced sFLT-1 production (Fig 4A2) (P<0.001) but did not alter sFLT-1 
production by HUVEC-NP monocytes co-culture (Fig 4A2). 
 
The basal expression levels of VEGF differed significantly between the various culture 
models as depicted in Fig 4B1. HUVEC monocultures expressed relatively higher levels of 
VEGF than HUVEC with NP or PE monocyte co-cultures (Fig 4B1). Stimulation of mono or 
co-cultures with TLR ligands did not result in altered VEGF production, except for HMGB1 
which appeared to induce production in by PE monocytes in culture (P<0.05) (Fig 4B2).  
 
1.3.4 Fibrinogen enhanced vascular adhesion in PE (Figure 4C) 
We also determined that soluble vascular cell adhesion molecule is induced by the 
interaction between monocytes from women with PE and vascular endothelial cells. As 
depicted in (Fig 4C1), HUVECs and NP/PE monocytes in monocultures produced very low 
levels of VCAM-1. However, cell-cell interactions during co-cultures experiments resulted in 
significant increases in VCAM-1 production, especially from HUVEC-PE monocytes co-
cultures (P<0.001) (Fig 4C1). Unstimulated HUVECs produced extremely low levels of 
VCAM-1. However, LPS, but not other TLR ligands, induced higher expression levels of 
VCAM-1 (P<0.05) (Fig 4C2).  Compared to the HUVEC-NP monocyte co-culture, the 
HUVEC-PE monocyte co-culture was associated with higher basal expression levels of 
VCAM-1 (P<0.05) (Fig 4C1), and an exaggerated VCAM-1 response on exposure to TLR 
bacterial ligands was also associated with (P<0.05) (Fig 4C2). Furthermore, the HUVEC-PE 
monocyte co-culture exhibited amplified VCAM-1 secretion in response to fibrinogen 
compared to the HUVEC-NP monocyte co-culture (P<0.001) (Fig 4C2).   
 
1.4 Discussion  
This study develops on our previous observation that fibrinogen, an endogenous ligand of 
TLR4, appears to induce PE monocytes to release inflammatory cytokines (Al-ofi et al., 2014), 
consistent with several studies that suggest a role for this receptor in the pathogenesis of PE 
(Al-ofi et al., 2012, Chen et al., 2015, Kulikova et al., 2016). We now show that fibrinogen 
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also appears to suppress the expression of inflammatory cytokine markers, induce the 
expression of cell adhesion molecules, and promote angiogenesis (by decreasing sFLT-1 
production) when PE monocytes and endothelial cells are established in co-culture.  
 
To the best of our knowledge, this is the first study to report the influence of activated human 
peripheral blood monocytes from patients with PE on endothelial cell function. We 
successfully established a co-culture model of human primary peripheral blood monocytes 
and HUVECs, and showed that PE monocytes in co-culture with HUVECs elaborated more 
IL-6 (pro-inflammatory cytokine), IL-18 and MCP-1 (chemokines) compared to NP monocyte-
HUVECS co-cultures, whereas the anti-inflammatory cytokine IL-10 expression levels was 
attenuated. 
  
Several studies have shown that IL-6 levels are elevated in the plasma of women with pre-
eclampsia and is involved in the pathogenesis of the condition (Freeman et al., 2004, 
Jonsson et al., 2006, Xiao et al., 2012). Being a multifunctional cytokine, IL-6 could play a 
key role in the modulation of angiogenesis in normotensive or hypertensive pregnancy (Desai 
et al., 2002). We have observed the elevation of IL-6 levels when HUVECs are established in 
co-culture with monocytes from women with PE, suggesting that IL-6 may promote vascular 
endothelial dysfunction in PE. Similarly, bacterial TLR2 and TLR4 ligands induced very high 
levels of IL-6 in co-cultures of PE monocytes with HUVECs, suggesting that vascular 
endothelial damage in PE may involve TLR-mediated mechanisms. It is intriguing that 
fibrinogen appeared to induce IL-6 production from monocultures of PE, but not NP 
monocytes (consistent with our previous report (Al-ofi et al., 2014)), but reduced its release 
from PE monocyte-HUVECs co-cultures. The potential mechanism of this observation is 
unclear but it seems plausible that monocyte release of IL-6 in the presence of fibrinogen 
may be altered by the presence of endothelial cells in the microvasculature. It is plausible 
that there is potential gene-gene association between IL-6 and fibrinogen, which could 
influence fibrinogen levels without influencing the development of cardiovascular disease 
(Carty et al., 2010).  It may also be that fibrinogen at this interface regulates monocyte 
activation and the release of cytokines in order to protect endothelial cells from inflammatory 
damage.  
 
It has been shown in porcine and murine models of vascular disease, and through in vitro 
experiments employing co-cultures of primary human monocytes and endothelial cell, that IL-
1β is a critical mediator of vascular inflammation (Morton et al., 2005, Chamberlain et al., 
2006, Ward et al., 2009). Data from the current study demonstrate that fibrinogen 
significantly induced IL-1β production by PE monocytes in mono- as well as co-cultures with 
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HUVECs, compared to NP monocytes. In another study, IL-1β, but not IL-1α, binds to 
fibrinogen and augments endothelial cell activity with increased NF-kβ, MCP-1, and nitric 
oxide production (Sahni et al., 2004). It is plausible that impairment of such binding in PE 
may lead to an increase of free IL-1β that modulates further vascular inflammation. IL-8 is a 
chemo-attractant for neutrophils and T cells, as well as a potent angiogenic marker (Koch et 
al., 1992), whilst MCP-1 is a chemo-attractant for mononuclear leukocytes (Leonard and 
Yoshimura, 1990). Kauma et al., demonstrated that plasma of women with severe PE 
expressed higher levels of IL-8 and MCP-1, and induced HUVEC to release IL-8 and MCP-1 
(Kauma et al., 2002). We have observed increased chemokine production from NP 
monocyte-HUVEC co-cultures, indicating their role in normal angiogenesis. Their amplified 
production from PE monocyte-HUVEC co-cultures is consistent with dysregulated 
angiogenesis in this model. The apparent modulatory effect of fibrinogen on the production of 
IL-8 from PE monocyte-HUVEC co-cultures suggests some role for fibrinogen during 
chemotaxis. MCP-1 production appeared amplified in PDG-treated HUVEC-PE monocyte co-
cultures, but reduced in fibrinogen-treated PE monocyte-HUVEC co-cultures. Taken together, 
our data suggest a complex role for TLR-2 and -4 receptors, and their ligands, in vascular 
endothelial homeostasis in PE, which merits further investigation.    
 
Circulating sFLT-1 is an anti-angiogenic protein whose levels are increased in PE, a 
condition in which it appears to suppress circulating PIGF and VEGF (Maynard et al., 2003, 
Chappell et al., 2013, Widmer et al., 2015). We have demonstrated that endothelial cells 
produced higher basal levels of sFLT-1, consistent with previous studies (Kendall et al., 1996, 
Barleon et al., 2001). For the first time however, we show that sFLT-1 production by HUVECs 
can be inhibited by fibrinogen. At variance with a previous study that reported that peripheral 
blood monocytes were capable of producing sFLT-1, and that this production was enhanced 
by LPS stimulation (Barleon et al., 2001), our results showed undetectable sFLT-1 release 
from PE or NP monocyte mono-cultures, even after TLR2 or TLR4 stimulation. One 
explanation for the differences between these studies could be the differing duration of 
culturing the monocytes – we incubated monocytes for 24 hours whilst Barleon et al (Barleon 
et al., 2001) did so for 72 hours. We also observed that monocytes from both pregnant 
groups attenuated sFLT-1 production by endothelial cells, but that PE monocytes did not 
appear to suppress its release to the same degree as NP monocytes. Although the LPS- or 
PDG-treated NP/PE co-cultures induced sFLT-1 production, an intriguing finding is that 
fibrinogen suppressed sFLT-1 production in the HUVEC-PE monocyte but not in the HUVEC-
NP monocyte co-culture. The plausible explanation for this observation is unclear but a role 
for fibrinogen in counteracting dysregulated angiogenesis in PE seems likely. We observed 
reduced soluble VEGFR-1 (sFLT-1) from HUVEC or HUVEC-PE monocyte co-cultures, in 
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agreement with one study that shows that endothelial cells cultured on fibrin matrices had 
markedly reduced growth factor receptors; particularly FGFR-1, FGFR-2 and VEGFR- 1 
(Tsou and Isik, 2001). Taken together, in addition to its well-established role in vascular 
haemostasis, our observations suggest that fibrinogen may contribute to endothelial repair in 
PE by enhancing angiogenesis through mechanisms that may include suppression of sFLT-1 
production. 
  
Furthermore, our result demonstrated reduced levels of VEGF in PE monocytes-HUVECs co-
culture compared to NP, confirming previous reports of increased sFlt-1 and reduced VEGF 
in PE (Lam et al., 2005). One unanticipated finding was that HMGB-1 treatment of the PE 
monocytes monoculture induced VEGF production whilst other TLR ligands did not.  This 
may be because HMGB-1 appears to stimulate VEGF production from PE monocytes 
through a different signalling pathway, such as the advanced glycation end product (RAGE) 
(Huang et al., 2010), as has been shown in oesophageal squamous cell carcinoma (Chen et 
al., 2012).  
 
Soluble adhesion molecules (VCAM-1, ICAM-1 and E-selectin) are elevated in the serum of 
patients with PE (Sibai, 2004, Al-ofi et al., 2012). Serum from women with PE also activates 
endothelial cells to express ICAM-1 but only in the presence of monocytes (Faas et al., 2010). 
Consistent with these previous studies (Sibai, 2004, Faas et al., 2010, Al-ofi et al., 2012), we 
observed increased expression levels of VCAM-1 by HUVEC-PE monocyte co-culture, and 
further enhanced induction by the bacterial TLR2/4 ligands (LPS and PDG) as well as by 
fibrinogen. Languino et al. inferred from their studies that fibrinogen acts as a molecular 
bridge between endothelial cells and leukocytes, enhancing the adhesion of leukocytes to the 
vascular endothelium and facilitating leukocyte trans-endothelial migration (Languino et al., 
1995). The fibrinogen-ICAM-1 interaction is associated with activation of MMPs and the 
digestion of junction proteins, thus disrupting endothelial layer integrity and increasing 
vascular permeability (Lominadze et al., 2010). Moreover, fibrinogen stimulates TLR4 
signalling in macrophages to release MMP-1 and MMP-9 (Hodgkinson et al., 2008). 
Fibrinogen seems to accumulate in the sub-endothelium at the site of vascular injury and 
may then act as matrices over which endothelial cells could attach, proliferate and spread 
(Lominadze et al., 2010).  
 
1.4.1 Conclusion 
We have shown that fibrinogen and HMGB1 variably induce pro-inflammatory cytokine 
production in co-cultures of monocytes and HUVECs similar to, but less strongly than, the 
TLR2 and TL4 ligands peptidoglycan and lipopolysaccharide. Our observations suggest that 
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fibrinogen appears to promote monocyte-endothelial cell adhesion thus may contribute to 
endothelial repair in PE by promoting angiogenesis through unknown mechanisms that may 
include strong suppression of sFLT-1 production. How fibrinogen modulates cell adhesion, 
angiogenesis and inflammation in normotensive and hypertensive pregnancy, and whether 
these functions are mediated by the TLR4 receptor or other fibrinogen receptors remain to be 
determined.  
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1.8 Figure legends  
Fig 1. Flow cytometry graphs representing monocyte and HUVECs co-culture 
 Flow cytometry pseudo-popular graph of monocyte-HUVECs co-culture (left panel-
FSC/SSC plot and right panel-CD14/CD146 plot); G1 is gated monocytes and G2 is gated 
endothelial cells. 
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Fig 2. Monocytes (MO) from patients with PE co-cultured with HUVECs exhibit an 
amplified inflammatory response of cytokines 
Basal levels of A. IL-6, B. IL-1β, C.IL-10, D. IL-8 and E. MCP-1productions by HUVEC 
monoculture, NP/PE MO monocultures, HUVEC-NP MO co-culture or HUVEC-PE MO co-
culture. Comparisons were made between NP and PE co-cultures versus HUVECs 
monocultures ^p < 0.05, ^^p< 0.01, and ^^^p < 0.001; or versus NP/PE monocytes 
monocultures †p < 0.05, ††p < 0.01 and †††p < 0.001. Values were illustrated as mean ± SEM. 
Statistical significance was determined by one-way ANOVA (Kruskal-Wallis test) (n=7-9).    
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Fig 3. Fibrinogen altered inflammatory cytokines levels from monocytes (MO) of 
patients with PE co-cultured with HUVECs  
Graphic representation of A. IL-6, B. IL-1β, C.IL-10, D. IL-8 and E. MCP-1 levels  by mono- 
or co-cultures in response to LPS, PDG, fibrinogen and HMGB1. Comparisons were made 
between unstimulated control versus stimulated cultures; and NP versus PE mono- or co-
cultures *p < 0.05, **p < 0.01, ***p < 0.001. Values were illustrated as mean ± SEM. Statistical 
significance was tow-way ANOVA (n=7-9).      
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Fig 4.  Fibrinogen attenuates sFLT-1-expression and enhanced vascular adhesion 
molecule expression in PE 
Basal levels of A1. sFLT-1, B1. VEGF and C1. VCAM-1 productions by HUVEC 
monoculture, NP/PE monocytes monocultures, HUVEC-NP monocytes co-cultures or 
HUVEC-PE monocytes co-cultures. Graphic representation of A2. sFLT-1, B2. VEGF and 
C2. VCAM-1 levels by mono- or co-cultures in response to LPS, PDG, fibrinogen and 
HMGB1.  Comparisons were made between NP and PE co-cultures versus HUVECs 
monocultures ^p < 0.05, ^^p< 0.01, and ^^^p < 0.001; or versus monocytes monocultures †p < 
0.05, ††p < 0.01 and †††p < 0.001;  unstimulated versus stimulated cultures; and NP versus PE 
mono- or co-cultures *p < 0.05, **p < 0.01,  ***p < 0.001. Values were illustrated as mean ± 
SEM. Statistical significance was determined by one-way ANOVA (Kruskal-Wallis test); or 
tow-way ANOVA (n=7-9).      
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1.7 Table 1 Subject characteristics 
 
 
 Normal pregnant  
(n = 9) 
Pre-eclampsia  
(n = 9) 
P value 
Age (years) 31.6 ± 6.4 31.5 ± 3.6 0.91 
Gestational age (weeks) 33.15 ± 4.0 33.18 ± 5.8 0.67 
Gravidity 1-4 1-3  
SBP (mm Hg) 114.0 ± 11.0 154 ± 5.8 0.0001 
DBP (mm Hg) 70.0 ± 10.0 90.8 ± 2.4 0.0001 
24-hour urine collection 
(g/24hrs) 
0 1.6 ± 1.7  
Urine Dipstick Protein Test 0 (1+ - 4+)  
 
